from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0412c/-

LFCtreatmentdescriptionclass of inhibitor

-0.608

Amikacinug/mL Amikacintranslation

-1.231

Cap5-10ug/mL Capreomycintranslation

-0.960

Rox10-50 ug/mL Roxithromycintranslation

-0.410

SM2-5 ug/mL Streptomycintranslation

-0.679

Tet5-10 ug/mL Tetracyclinetranslation

-0.561

Rif0.2-5ug/mL Rifampicintranscription

-0.247

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.630

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.541

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.307

CPZ10-50 ug/mL Chlorpromazinerespiration

0.305

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.540

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.719

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.437

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.249

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.281

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.343

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.117

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.524

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.944

KCN5-20 ug/mL Potassium cyaniderespiration

0.459

NaN30.2-2 mM Sodium aziderespiration

0.296

Nigericin50 uM Nigericinrespiration

0.760

TRC10-150 ug/mL Triclosanrespiration

1.681

TRZ10-25 ug/mL Thioridazinerespiration

-0.450

Valinomycin0.5-10 uM Valinomycinrespiration

-0.143

ZnSO42 mM ZnSO4respiration

0.740

menadione6-10 ug/mL Menadionerespiration

-0.550

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.464

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.383

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.470

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.408

NRP_1Non-replicating persistence stage 1dosRassociated

-0.481

Amp0.2mg/mL AmpicillincellWall

-0.603

Cephalexin20-100 ug/mL CephalexincellWall

0.689

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.726

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.402

EMB10-20 ug/mL EthambutolcellWall

0.407

Eta12-40 ug/mL EthionamidecellWall

0.323

INH0.2-0.4 ug/mL IsoniazidcellWall

0.562

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.162

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.340

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.646

BZA0.12 mg/mL BenzamidearomaticAmides

0.238

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.319

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.008

H2O24 mM hydrogen peroxideDNAdamaging

-0.076

Levo10 ug/mL LevofloxacinDNAdamaging

-0.306

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.142

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.047

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.379

UVUV-irradiationDNAdamaging

0.426

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.839

Antimycin12.5-50 ug/mL Antimycin A?

-0.550

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.560

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.699

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.913

PA8240.2-2 ug/mL PA-824?

0.463

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.621

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.643

Verapamil50 uM Verapamil?

-0.604

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.434

methoxatin10-20 ug/mL Methoxatin?